Abstract
Secondary haemophagocytic lymphohistiocytosis is a rare but fatal complication of tuberculosis. We describe two cases, and review the local and international experience on the management of this clinical entity. Prompt treatment with anti-tuberculous drugs forms the cornerstone of therapeutic success.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antitubercular Agents / therapeutic use
-
Female
-
Humans
-
Lymphohistiocytosis, Hemophagocytic / diagnosis
-
Lymphohistiocytosis, Hemophagocytic / drug therapy
-
Lymphohistiocytosis, Hemophagocytic / etiology*
-
Male
-
Mycobacterium tuberculosis / isolation & purification*
-
Tuberculosis / complications*
-
Tuberculosis / diagnosis
-
Tuberculosis / drug therapy